Lexicon Pharmaceuticals Inc (LXRX)
0.8634
+0.09
(+11.88%)
USD |
NASDAQ |
Nov 22, 16:00
0.8755
+0.01
(+1.40%)
Pre-Market: 20:00
Lexicon Pharmaceuticals Market Cap: 312.11M for Nov. 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 22, 2024 | 312.11M |
| November 21, 2024 | 278.96M |
| November 20, 2024 | 291.87M |
| November 19, 2024 | 318.44M |
| November 18, 2024 | 327.15M |
| November 15, 2024 | 352.53M |
| November 14, 2024 | 383.18M |
| November 13, 2024 | 394.03M |
| November 12, 2024 | 430.18M |
| November 11, 2024 | 459.10M |
| November 08, 2024 | 459.10M |
| November 07, 2024 | 469.94M |
| November 06, 2024 | 437.41M |
| November 05, 2024 | 430.18M |
| November 04, 2024 | 435.60M |
| November 01, 2024 | 441.02M |
| October 31, 2024 | 704.91M |
| October 30, 2024 | 704.91M |
| October 29, 2024 | 733.83M |
| October 28, 2024 | 672.38M |
| October 25, 2024 | 650.69M |
| October 24, 2024 | 665.15M |
| October 23, 2024 | 672.38M |
| October 22, 2024 | 701.30M |
| October 21, 2024 | 704.91M |
| Date | Value |
|---|---|
| October 18, 2024 | 751.90M |
| October 17, 2024 | 726.60M |
| October 16, 2024 | 690.45M |
| October 15, 2024 | 647.07M |
| October 14, 2024 | 647.07M |
| October 11, 2024 | 629.00M |
| October 10, 2024 | 610.92M |
| October 09, 2024 | 589.23M |
| October 08, 2024 | 607.31M |
| October 07, 2024 | 607.31M |
| October 04, 2024 | 610.92M |
| October 03, 2024 | 582.00M |
| October 02, 2024 | 582.00M |
| October 01, 2024 | 571.16M |
| September 30, 2024 | 567.54M |
| September 27, 2024 | 578.39M |
| September 26, 2024 | 556.70M |
| September 25, 2024 | 545.85M |
| September 24, 2024 | 567.54M |
| September 23, 2024 | 571.16M |
| September 20, 2024 | 600.08M |
| September 19, 2024 | 610.92M |
| September 18, 2024 | 592.85M |
| September 17, 2024 | 585.62M |
| September 16, 2024 | 589.23M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
123.35M
Minimum
Nov 02 2020
1.286B
Maximum
Feb 02 2021
473.06M
Average
449.63M
Median
Market Cap Benchmarks
| Viatris Inc | 15.96B |
| Halozyme Therapeutics Inc | 6.234B |
| Perspective Therapeutics Inc | 234.53M |
| Quanterix Corp | 450.95M |
| Autonomix Medical Inc | 7.235M |
Market Cap Related Metrics
| PS Ratio | 48.00 |
| Price to Book Value | 1.748 |
| Price | 0.8634 |
| Earnings Yield | -86.87% |